Erlotinib versus chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations: Interim results of the European Erlotinib Versus Chemotherapy (EURTAC) phase III randomized trial.
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7503-7503
◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 10541-10541
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7588-7588
◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7593-7593
Keyword(s):